Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	Z disc	SORBS2 ANK2 ANK3 XIRP2 RTL1 SPHKAP SYNE2 DMD AHNAK2	4.34e-06	151	171	9	GO:0030018
GeneOntologyCellularComponent	I band	SORBS2 ANK2 ANK3 XIRP2 RTL1 SPHKAP SYNE2 DMD AHNAK2	9.37e-06	166	171	9	GO:0031674
GeneOntologyCellularComponent	filopodium membrane	MYO10 PDPN SYNE2 DMD	2.32e-05	21	171	4	GO:0031527
GeneOntologyCellularComponent	costamere	ANK2 ANK3 DMD AHNAK2	2.82e-05	22	171	4	GO:0043034
GeneOntologyCellularComponent	sarcomere	SORBS2 ANK2 ANK3 XIRP2 RTL1 SPHKAP SYNE2 DMD AHNAK2	2.18e-04	249	171	9	GO:0030017
GeneOntologyCellularComponent	anchoring junction	DCHS2 SORBS2 ANK2 ANK3 SHROOM2 PDPN EFNA5 TIAM1 PTPRK XIRP2 TJP1 HPN SYNE2 NHS ALCAM FGFR4 DMD WNK4 ADGRL3	4.14e-04	976	171	19	GO:0070161
GeneOntologyCellularComponent	myofibril	SORBS2 ANK2 ANK3 XIRP2 RTL1 SPHKAP SYNE2 DMD AHNAK2	4.28e-04	273	171	9	GO:0030016
GeneOntologyCellularComponent	centriole	KIAA0586 CEP192 CEP170 ALMS1 STARD9 CEP295 WDR62	5.47e-04	172	171	7	GO:0005814
GeneOntologyCellularComponent	contractile muscle fiber	SORBS2 ANK2 ANK3 XIRP2 RTL1 SPHKAP SYNE2 DMD AHNAK2	6.61e-04	290	171	9	GO:0043292
HumanPheno	Bulbous nose	ESS2 BICRA INTS1 JMJD1C FREM1 EDEM3 TRPM3 ASXL3 LTBP3 TAF1 STAG2 WDR62	6.55e-06	201	65	12	HP:0000414
Domain	ZU5	ANK2 ANK3 TJP1	5.87e-05	9	169	3	SM00218
Domain	ZU5	ANK2 ANK3 TJP1	8.34e-05	10	169	3	PS51145
Domain	Cadherin	DCHS2 PCDHGB5 PCDHGB3 FREM3 FREM1 CELSR2 PCDHGA8	9.96e-05	118	169	7	IPR002126
Domain	GAIN_dom_N	CELSR2 ADGRL2 ADGRL3	1.14e-04	11	169	3	IPR032471
Domain	GAIN	CELSR2 ADGRL2 ADGRL3	1.14e-04	11	169	3	PF16489
Domain	ZU5	ANK2 ANK3 TJP1	1.51e-04	12	169	3	PF00791
Domain	ZU5_dom	ANK2 ANK3 TJP1	1.51e-04	12	169	3	IPR000906
Domain	Latrophilin	ADGRL2 ADGRL3	2.43e-04	3	169	2	PF02354
Domain	ALMS_motif	ALMS1 CEP295	2.43e-04	3	169	2	IPR029299
Domain	ALMS_motif	ALMS1 CEP295	2.43e-04	3	169	2	PF15309
Domain	GPCR_2_latrophilin_rcpt_C	ADGRL2 ADGRL3	2.43e-04	3	169	2	IPR003334
Domain	CH	EHBP1 LRCH2 SYNE2 MACF1 DMD	3.05e-04	65	169	5	SM00033
Domain	CH	EHBP1 LRCH2 SYNE2 MACF1 DMD	4.30e-04	70	169	5	PF00307
Domain	-	EHBP1 LRCH2 SYNE2 MACF1 DMD	4.60e-04	71	169	5	1.10.418.10
Domain	CH	EHBP1 LRCH2 SYNE2 MACF1 DMD	5.23e-04	73	169	5	PS50021
Domain	CH-domain	EHBP1 LRCH2 SYNE2 MACF1 DMD	5.92e-04	75	169	5	IPR001715
Domain	Gal_Lectin	ADGRL2 ADGRL3	8.00e-04	5	169	2	PF02140
Domain	VCX_VCY	VCX3A VCX3B	8.00e-04	5	169	2	PF15231
Domain	GPCR_2_latrophilin	ADGRL2 ADGRL3	8.00e-04	5	169	2	IPR003924
Domain	Lectin_gal-bd_dom	ADGRL2 ADGRL3	8.00e-04	5	169	2	IPR000922
Domain	SUEL_LECTIN	ADGRL2 ADGRL3	8.00e-04	5	169	2	PS50228
Domain	VCX/VCY1	VCX3A VCX3B	8.00e-04	5	169	2	IPR026653
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	EHBP1 TET2 GAPVD1 SORBS2 NAA15 ERCC6L DCP2 CEP192 LYST WDR59 CEP170 FAM171A1 PTPN14 ALMS1 FAM13A TIAM1 TJP1 PHF3 STARD9 SYNE2 ANKRD17 NHS MACF1 TMEM102 CRYBG3 WNK4 EPB41 WDR62 AHNAK2 CCSER1	4.98e-17	861	173	30	36931259
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	EHBP1 TET2 RGPD2 GAPVD1 ZGRF1 DVL2 ZNF318 ZBTB1 JMJD1C NOL4L ALMS1 UBR5 ANKRD17 CHD6 TAF1 CRYBG3 LRBA WDR62	4.18e-12	418	173	18	34709266
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	EHBP1 GAPVD1 ANK3 DVL2 ZNF318 JMJD1C PTPN14 ALMS1 TJP1 NHS MACF1 CRYBG3 LRBA AHNAK2	6.98e-11	263	173	14	34702444
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RGPD2 ERCC5 ANK2 PCDHGB5 PCDHGB3 MYNN ZNF318 ZFC3H1 TEX14 LYST DNTTIP2 FER1L6 C6orf118 NOP14 BRCA1 AP2B1 TJP1 SLC22A14 STARD9 TNN SYNE2 MACF1 CEP295 CHD6 ALCAM DMD PCDHGA8 STAG2 CAVIN2	1.47e-10	1442	173	29	35575683
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SORBS2 LRCH2 MYO10 CEP192 RNF157 MFAP3L UBR5 PHF3 STARD9 SPHKAP PACS2 MACF1 CHD6 ANKRD12 ADGRL3 PLXNB3	2.61e-10	407	173	16	12693553
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZBTB2 BICRA POLR2E DVL2 ZNF318 TSPYL1 ELL3 DNTTIP2 CEP170 KAT7 EDEM3 PTPN14 ALMS1 BRCA1 UBR5 HPN DHPS ANKRD17 MACF1 CEP295 TAF1 CRYBG3 ADGRL2 WDR62	1.84e-09	1116	173	24	31753913
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	CACNA1A PSD2 PDZD7 PRDM4 SHROOM2 PCNX2 ALMS1 XIRP2 PHF3 STARD9 CEP295 ZNF282	2.42e-09	233	173	12	37704626
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	EHBP1 ZBTB2 KIAA0586 SYTL2 GPAM ZFC3H1 MORC2 FANCM JMJD1C WDR59 CEP170 PARP4 ALMS1 TRPM3 MACF1 CCSER1	4.09e-09	493	173	16	15368895
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	GAPVD1 LRCH2 KIAA0586 CEP192 ALMS1 UBR5 NHS MACF1 CRYBG3 WDR62 PPP6R3	9.12e-09	209	173	11	36779422
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	EHBP1 GAPVD1 NAA15 ANK2 ERCC6L DVL2 TACC2 ZNF318 DNTTIP2 CEP170 ALMS1 AP2B1 TJP1 ANKRD17 MACF1 LRBA EPB41 WDR62 PPP6R3 AHNAK2 NOL8	9.62e-09	934	173	21	33916271
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CACNA1A RGPD2 SORBS2 LRCH2 ANK2 ANK3 DVL2 NSD1 ZNF318 ZBTB1 CEP170 FAM171A1 FRY CELSR2 AP2B1 UBR5 TJP1 SPHKAP SYNE2 ANKRD17 MACF1	1.63e-08	963	173	21	28671696
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	GAPVD1 NAA15 INTS1 NSD1 ZNF318 DNTTIP2 CEP170 NOP14 AP2B1 UBR5 TJP1 PHF3 SYNE2 ANKRD17 MACF1 STAG2 PPP6R3	3.36e-08	653	173	17	22586326
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	TET2 DCHS2 SORBS2 ANK2 ANK3 TMEM59 MYNN ZFC3H1 PRDM4 SHROOM2 WDR59 FRY THOP1 TIAM1 AP2B1 PTPRK TJP1 MACF1 CHD6 LTBP3 TAF1 LRBA PLXNB3	1.18e-07	1285	173	23	35914814
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	GAPVD1 ANK3 ERCC6L NSD1 ZNF318 JMJD1C CEP170 PTPN14 ALMS1 TJP1 PHF3 TAF1 LRBA EPB41 PPP6R3	1.21e-07	549	173	15	38280479
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	GAPVD1 LRCH2 DVL2 ZNF318 ZFC3H1 ZBTB1 DNTTIP2 CEP170 UBR5 PHF3 ANKRD17 SGO2 PPP6R3	3.60e-07	440	173	13	34244565
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	EHBP1 BDP1 CDC42BPG ANK3 BICRA CEP192 SHROOM2 NAALADL2 JMJD1C PCNX2 CEP170 THOP1 EFNA5 FAM13A TJP1 HPN ANKRD17 MACF1 CHD6 ANKRD12 ALCAM LRBA STAG2 EPB41	4.09e-07	1489	173	24	28611215
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	GAPVD1 SORBS2 LRCH2 CEP192 TSPYL1 CEP170 PTPN14 ALMS1 UBR5 TJP1 CEP295 WDR62 PPP6R3	4.19e-07	446	173	13	24255178
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	ZBTB2 POLR2E NSD1 ZFC3H1 TSPYL1 FANCM ZBTB1 JMJD1C BRCA1 UBR5 PHF3 SGO2 CAVIN2	4.99e-07	453	173	13	29656893
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	TET2 SYTL2 GPAM CEP192 FANCM TRPM3 PPP6R3	7.74e-07	101	173	7	10997877
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	EHBP1 GAPVD1 ESS2 ERCC6L MYO10 POLR2E DVL2 SNRK ZBTB1 CEP170 KAT7 DNAAF3 AP2B1 UBR5 TJP1 ZC3H12C DMD PPP6R3 BORA	1.16e-06	1038	173	19	26673895
Pubmed	An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan.	ANK2 ANK3 DMD	1.20e-06	5	173	3	19109891
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	ESS2 ZNF318 ZFC3H1 TSPYL1 MORC2 NOP14 BRCA1 AP2B1 NOL8	1.87e-06	222	173	9	37071664
Pubmed	Myotubularin-related proteins 3 and 4 interact with polo-like kinase 1 and centrosomal protein of 55 kDa to ensure proper abscission.	GAPVD1 ANK3 ERCC6L DVL2 ZBTB1 UBR5 PPP6R3 BORA	2.06e-06	167	173	8	25659891
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	GAPVD1 ERCC5 ANK3 CYP17A1 NSD1 TACC2 ZNF318 CEP192 SHROOM2 DNTTIP2 KAT7 NOL4L THOP1 ANKRD17 MACF1 CEP295 ANKRD12 SUCO STAG2	2.19e-06	1084	173	19	11544199
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	ESS2 INTS1 NSD1 MORC2 JMJD1C DNTTIP2 KAT7 NOP14 BRCA1 PHF3 SGO2 CHD6 TAF1 STAG2	2.42e-06	608	173	14	36089195
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	EHBP1 GAPVD1 ANK2 ANK3 ERCC6L DVL2 JMJD1C CEP170 FAM171A1 ANKRD17 MACF1 CRYBG3 LRBA ADGRL2 EPB41	2.89e-06	708	173	15	39231216
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ABCC3 ERCC6L HORMAD1 FER1L6 PARP4 ASXL3 SYNE2 NXF5 ANKRD17 CEP295 CHD6 STAG2 CAVIN2 AHNAK2	4.21e-06	638	173	14	31182584
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	ZNF318 CEP192 JMJD1C CEP170 ALMS1 UBR5 TJP1 ANKRD12	4.23e-06	184	173	8	32908313
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	EHBP1 CACNA1A RGPD2 SORBS2 NAA15 ANK2 ANK3 DVL2 SNRK TACC2 SHROOM2 CEP170 CELSR2 TJP1 SPHKAP MACF1 CRYBG3 EPB41 ADGRL3	4.46e-06	1139	173	19	36417873
Pubmed	A genome-wide association study on thyroid function and anti-thyroid peroxidase antibodies in Koreans.	TPO ZGRF1 PTPN14	6.65e-06	8	173	3	24722205
Pubmed	Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	BDP1 ASXL3 SPHKAP CEP295 ZC3H12C CCSER1	1.26e-05	102	173	6	11214970
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	NAA15 ANK2 ANK3 TMEM59 CEP192 ZFC3H1 DNTTIP2 FAM171A1 PTPN14 NOP14 TIAM1 UBR5 SYNE2 DHPS MACF1 CRYBG3 ADGRL2 SUCO WDR62 PPP6R3 NOL8	1.72e-05	1487	173	21	33957083
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	SNRK ALMS1 NRXN2 UBR5 PHF3 SYNE2 MACF1 CHD6	1.83e-05	225	173	8	12168954
Pubmed	A protein interaction landscape of breast cancer.	GAPVD1 ANK3 BICRA DDX60 CEP170 PTPN14 BRCA1 AP2B1 UBR5 DHPS MACF1 CAVIN2 PPP6R3	1.91e-05	634	173	13	34591612
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	GAPVD1 ESS2 ERCC6L SYTL2 JMJD1C WDR59 CEP170 EDEM3 ALMS1 TJP1 PHF3 CEP295 CHD6 WDR62	1.99e-05	733	173	14	34672954
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ANK3 POLR2E CEP192 FAM171A1 CNNM1 PTPN14 NOP14 TIAM1 PTPRK TJP1 SYNE2 DHPS NHS CRYBG3 DMD ADGRL2 PPP6R3	2.11e-05	1049	173	17	27880917
Pubmed	Inhibition of autophagy in theca cells induces CYP17A1 and PAI-1 expression via ROS/p38 and JNK signalling during the development of polycystic ovary syndrome.	CYP17A1 SERPINE1	2.46e-05	2	173	2	32199904
Pubmed	CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women.	CYP17A1 BRCA1	2.46e-05	2	173	2	17307805
Pubmed	Modulation of neuritogenesis by a protein implicated in X-linked mental retardation.	VCX3A VCX3B	2.46e-05	2	173	2	19812318
Pubmed	Latrophilin GPCRs direct synapse specificity by coincident binding of FLRTs and teneurins.	ADGRL2 ADGRL3	2.46e-05	2	173	2	30792275
Pubmed	Latrophilin GPCR signaling mediates synapse formation.	ADGRL2 ADGRL3	2.46e-05	2	173	2	33646123
Pubmed	Modulation of myocardin function by the ubiquitin E3 ligase UBR5.	UBR5 MYOCD	2.46e-05	2	173	2	20167605
Pubmed	BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer.	DDIT3 BRCA1	2.46e-05	2	173	2	21700680
Pubmed	Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.	CYP17A1 JMJD1C	2.46e-05	2	173	2	26414697
Pubmed	GLTSCR1 coordinates alternative splicing and transcription elongation of ZO1 to regulate colorectal cancer progression.	BICRA TJP1	2.46e-05	2	173	2	35218185
Pubmed	The ankyrin-B C-terminal domain determines activity of ankyrin-B/G chimeras in rescue of abnormal inositol 1,4,5-trisphosphate and ryanodine receptor distribution in ankyrin-B (-/-) neonatal cardiomyocytes.	ANK2 ANK3	2.46e-05	2	173	2	11781319
Pubmed	Structural basis of diverse membrane target recognitions by ankyrins.	ANK2 ANK3	2.46e-05	2	173	2	25383926
Pubmed	NHS-A isoform of the NHS gene is a novel interactor of ZO-1.	TJP1 NHS	2.46e-05	2	173	2	19447104
Pubmed	Interleukin-1α deficiency attenuates endoplasmic reticulum stress-induced liver damage and CHOP expression in mice.	DDIT3 IL1A	2.46e-05	2	173	2	26022690
Pubmed	FANCM regulates repair pathway choice at stalled replication forks.	FANCM BRCA1	2.46e-05	2	173	2	33882298
Pubmed	The 4G/5G PAI-1 polymorphism influences the endothelial response to IL-1 and the modulatory effect of pravastatin.	SERPINE1 IL1A	2.46e-05	2	173	2	16879223
Pubmed	PAI-1-regulated miR-21 defines a novel age-associated fibrogenic pathway in muscular dystrophy.	SERPINE1 DMD	2.46e-05	2	173	2	22213800
Pubmed	Cep295 is a conserved scaffold protein required for generation of a bona fide mother centriole.	CEP192 CEP295	2.46e-05	2	173	2	27562453
Pubmed	ALMS1 and Alström syndrome: a recessive form of metabolic, neurosensory and cardiac deficits.	ALMS1 CEP295	2.46e-05	2	173	2	30421101
Pubmed	Microchidia protein 2, MORC2, downregulates the cytoskeleton adapter protein, ArgBP2, via histone methylation in gastric cancer cells.	SORBS2 MORC2	2.46e-05	2	173	2	26476214
Pubmed	Oncogenic functions of protein kinase D2 and D3 in regulating multiple cancer-related pathways in breast cancer.	MYO10 TMEM59 FREM3 PCNX2 UBR5 TJP1	2.62e-05	116	173	6	30652415
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	INTS1 NSD1 ZNF318 JMJD1C CEP170 ALMS1 ANKRD17 LRBA	3.08e-05	242	173	8	34011540
Pubmed	HENA, heterogeneous network-based data set for Alzheimer's disease.	ZFC3H1 CEP170 ALMS1 MACF1 DMD CCSER1	3.17e-05	120	173	6	31413325
Pubmed	A mutation in the tuft mouse disrupts TET1 activity and alters the expression of genes that are crucial for neural tube closure.	TET2 DVL2 CELSR2	3.33e-05	13	173	3	26989192
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	GAPVD1 SORBS2 ERCC5 ERCC6L ZNF318 MORC2 NOL4L FAM13A PHF3 PACS2 ANKRD17 STAG2 WDR62 PPP6R3	3.60e-05	774	173	14	15302935
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	BDP1 ESS2 ZGRF1 TACC2 ZNF318 CEP192 PTPN14 ALMS1 UBR5 MACF1 CRYBG3 PPP6R3	4.21e-05	588	173	12	38580884
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	ANK2 JMJD1C DNTTIP2 CEP170 PARP4 ALMS1 XIRP2 SYNE2 MACF1 TAF1 STAG2	4.29e-05	497	173	11	23414517
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	DVL2 ZNF318 JMJD1C CEP170 TJP1 ANKRD17 EPB41 AHNAK2	4.59e-05	256	173	8	33397691
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	TET2 SORBS2 ALMS1 NRXN2 MACF1 PLXNB3	4.97e-05	130	173	6	12421765
Pubmed	Ankyrin-G regulated epithelial phenotype is required for mouse lens morphogenesis and growth.	ANK2 ANK3 TJP1	5.27e-05	15	173	3	30562487
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	EHBP1 ANK3 FAM171A1 PTPN14 CELSR2 NHS MACF1 LRBA DMD ADGRL2	5.35e-05	421	173	10	36976175
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	GAPVD1 ERCC5 POLR2E INTS1 CEP192 LYST DNTTIP2 CEP170 KAT7 EFNA5 AP2B1 RTL1 DHPS FGFR4 PPP6R3	5.43e-05	910	173	15	36736316
Pubmed	Aurora B opposes PP1 function in mitosis by phosphorylating the conserved PP1-binding RVxF motif in PP1 regulatory proteins.	CEP192 BRCA1 UBR5	6.46e-05	16	173	3	29764992
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	EHBP1 ABCC3 CEP192 TSPYL1 CNNM1 NOP14 UBR5 SERPINE1 MACF1 ALCAM TMEM102 LRBA CAVIN2	6.92e-05	719	173	13	35337019
Pubmed	A family of heptahelical receptors with adhesion-like domains: a marriage between two super families.	ADGRL2 ADGRL3	7.36e-05	3	173	2	10994649
Pubmed	Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women.	CYP17A1 BRCA1	7.36e-05	3	173	2	24629213
Pubmed	Gene deletion of Interleukin-1α reduces ER stress-induced CHOP expression in macrophages and attenuates the progression of atherosclerosis in apoE-deficient mice.	DDIT3 IL1A	7.36e-05	3	173	2	37146542
Pubmed	Ankyrin B and Ankyrin B variants differentially modulate intracellular and surface Cav2.1 levels.	CACNA1A ANK2	7.36e-05	3	173	2	31477143
Pubmed	Are CYP17 genotypes a biomarker for ovarian cancer in patients with cancer history in their family?	CYP17A1 BRCA1	7.36e-05	3	173	2	16783967
Pubmed	FANCM, BRCA1, and BLM cooperatively resolve the replication stress at the ALT telomeres.	FANCM BRCA1	7.36e-05	3	173	2	28673972
Pubmed	The ammonium transporter RhBG: requirement of a tyrosine-based signal and ankyrin-G for basolateral targeting and membrane anchorage in polarized kidney epithelial cells.	ANK2 ANK3	7.36e-05	3	173	2	15611082
Pubmed	Interleukin-1 induction of type-1 plasminogen activator inhibitor (PAI-1) gene expression in the mouse hepatocyte line, AML 12.	SERPINE1 IL1A	7.36e-05	3	173	2	8816919
Pubmed	Induction of human ADAMTS-2 gene expression by IL-1α is mediated by a multiple crosstalk of MEK/JNK and PI3K pathways in osteoblast like cells.	ADAMTS2 IL1A	7.36e-05	3	173	2	26232334
Pubmed	Interleukin-1 increases SERPINE1 expression in human granulosa-lutein cell via P50/P52 signaling pathways.	SERPINE1 IL1A	7.36e-05	3	173	2	38777211
Pubmed	HSF1, in association with MORC2, downregulates ArgBP2 via the PRC2 family in gastric cancer cells.	SORBS2 MORC2	7.36e-05	3	173	2	29339121
Pubmed	Regulation of mouse steroidogenesis by WHISTLE and JMJD1C through histone methylation balance.	CYP17A1 JMJD1C	7.36e-05	3	173	2	20530532
Pubmed	Modeling microcephaly with cerebral organoids reveals a WDR62-CEP170-KIF2A pathway promoting cilium disassembly in neural progenitors.	CEP170 WDR62	7.36e-05	3	173	2	31197141
Pubmed	Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy.	LYST DMD	7.36e-05	3	173	2	29242210
Pubmed	ZGRF1 promotes end resection of DNA homologous recombination via forming complex with BRCA1/EXO1.	ZGRF1 BRCA1	7.36e-05	3	173	2	34552057
Pubmed	XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expression.	ERCC5 BRCA1	7.36e-05	3	173	2	19289372
Pubmed	The multiple actions of black widow spider toxins and their selective use in neurosecretion studies.	ADGRL2 ADGRL3	7.36e-05	3	173	2	15066411
Pubmed	The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers.	CYP17A1 BRCA1	7.36e-05	3	173	2	20798986
Pubmed	Ankyrin-B regulates Cav2.1 and Cav2.2 channel expression and targeting.	CACNA1A ANK2	7.36e-05	3	173	2	24394417
Pubmed	BRCA1 downregulates the kinase activity of Polo-like kinase 1 in response to replication stress.	BRCA1 BORA	7.36e-05	3	173	2	24067368
Pubmed	WDR62 is involved in spindle assembly by interacting with CEP170 in spermatogenesis.	CEP170 WDR62	7.36e-05	3	173	2	31533924
Pubmed	Ankyrin-Tiam1 interaction promotes Rac1 signaling and metastatic breast tumor cell invasion and migration.	ANK3 TIAM1	7.36e-05	3	173	2	10893266
Pubmed	Centriolar association of ALMS1 and likely centrosomal functions of the ALMS motif-containing proteins C10orf90 and KIAA1731.	ALMS1 CEP295	7.36e-05	3	173	2	20844083
Pubmed	Human ankyrins and their contribution to disease biology: An update.	ANK2 ANK3	7.36e-05	3	173	2	33410423
Pubmed	Synaptotagmin 2 couples mucin granule exocytosis to Ca2+ signaling from endoplasmic reticulum.	ANK2 SYTL2	7.36e-05	3	173	2	19208631
Pubmed	Analysis of the VCX3A, VCX2 and VCX3B genes shows that VCX3A gene deletion is not sufficient to result in mental retardation in X-linked ichthyosis.	VCX3A VCX3B	7.36e-05	3	173	2	18076704
Pubmed	Lateral membrane biogenesis in human bronchial epithelial cells requires 190-kDa ankyrin-G.	ANK3 TJP1	7.36e-05	3	173	2	14757759
Pubmed	Ankyrin-dependent Na+ channel clustering prevents neuromuscular synapse fatigue.	ANK2 ANK3	7.36e-05	3	173	2	34289389
Pubmed	alpha-Latrotoxin and its receptors: neurexins and CIRL/latrophilins.	ADGRL2 ADGRL3	7.36e-05	3	173	2	11520923
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	ESS2 ERCC6L TACC2 ZNF318 JMJD1C DNTTIP2 CEP170 TJP1 PHF3 AHNAK2	8.31e-05	444	173	10	34795231
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	BICRA NSD1 ZNF318 FANCM JMJD1C DNTTIP2 CEP170 BRCA1 TJP1 PHF3 SGO2 TAF1 STAG2 EPB41 NOL8	9.17e-05	954	173	15	36373674
Interaction	YWHAG interactions	EHBP1 TET2 GAPVD1 SORBS2 NAA15 ERCC6L DCP2 DVL2 CEP192 SHROOM2 LYST DNTTIP2 CEP170 FAM171A1 PTPN14 ALMS1 FAM13A TIAM1 TJP1 PHF3 STARD9 SYNE2 PACS2 ANKRD17 NHS MACF1 TMEM102 LRBA SUCO EPB41 WDR62 PPP6R3 AHNAK2 CCSER1	7.23e-10	1248	168	34	int:YWHAG
Interaction	YWHAH interactions	EHBP1 TET2 CDC42BPG GAPVD1 SORBS2 LRCH2 ERCC6L CEP192 LYST CEP170 FAM171A1 PTPN14 ALMS1 FAM13A TIAM1 TJP1 PHF3 STARD9 SYNE2 PACS2 ANKRD17 NHS MACF1 TMEM102 CRYBG3 LRBA SUCO EPB41 WDR62 AHNAK2 CCSER1	2.18e-09	1102	168	31	int:YWHAH
Interaction	SFN interactions	TET2 GAPVD1 SORBS2 ERCC6L CEP192 TEX14 LYST CEP170 FAM171A1 KAT7 PTPN14 ALMS1 FAM13A TIAM1 TJP1 PHF3 PACS2 ANKRD17 NHS MACF1 CRYBG3 WDR62 AHNAK2 CCSER1	3.40e-09	692	168	24	int:SFN
Interaction	EGLN3 interactions	TET2 GAPVD1 ESS2 LRCH2 ERCC6L DCP2 POLR2E KIAA0586 DVL2 ZNF318 CEP192 TSPYL1 ZBTB1 JMJD1C WDR59 ZFPM2 CEP170 FAM171A1 PARP4 BRCA1 PTPRK UBR5 PHF3 ANKRD17 SGO2 CEP295 ZNF282 WDR62 PPP6R3 BORA	3.12e-07	1296	168	30	int:EGLN3
Interaction	RNF43 interactions	EHBP1 GAPVD1 ANK3 DVL2 ZNF318 JMJD1C PTPN14 ALMS1 UBR5 TJP1 NHS MACF1 CRYBG3 LRBA PPP6R3 AHNAK2	6.07e-07	427	168	16	int:RNF43
Interaction	YWHAB interactions	TET2 GAPVD1 SORBS2 DVL2 CEP192 LYST CEP170 FAM171A1 PTPN14 FAM13A TIAM1 TJP1 PHF3 STARD9 PACS2 ANKRD17 NHS PRMT9 MACF1 FGFR4 SUCO EPB41 WDR62 AHNAK2 CCSER1	1.12e-06	1014	168	25	int:YWHAB
Interaction	PHF21A interactions	EHBP1 GAPVD1 ZGRF1 DVL2 ZNF318 ZBTB1 JMJD1C ALMS1 UBR5 CHD6 TAF1 CRYBG3 LRBA WDR62	1.16e-06	343	168	14	int:PHF21A
Interaction	YWHAZ interactions	TET2 BDP1 CDC42BPG GAPVD1 SORBS2 TACC2 CEP192 LYST CEP170 FAM171A1 PTPN14 FAM13A BRCA1 TIAM1 AP2B1 TJP1 PHF3 STARD9 ASXL3 SYNE2 PACS2 ANKRD17 NHS MACF1 TMEM102 SUCO EPB41 WDR62 CCSER1	1.44e-06	1319	168	29	int:YWHAZ
Interaction	YWHAQ interactions	TET2 ZBTB2 SORBS2 DVL2 CEP192 LYST CEP170 FAM171A1 PTPN14 FAM13A BRCA1 TIAM1 TJP1 STARD9 PACS2 ANKRD17 NHS MACF1 TMEM102 LRBA SUCO WNK4 EPB41 WDR62 CCSER1	6.31e-06	1118	168	25	int:YWHAQ
Interaction	TRIM66 interactions	BICRA ZNF318 CEP170 EDEM3 PTPN14 ALMS1 CEP295 CRYBG3 ADGRL2 WDR62	8.87e-06	205	168	10	int:TRIM66
Interaction	WWTR1 interactions	GAPVD1 ANK3 ERCC6L DVL2 ZNF318 JMJD1C CEP170 PTPN14 ALMS1 TJP1 PHF3 LRBA EPB41 PPP6R3	1.26e-05	422	168	14	int:WWTR1
Interaction	HDAC1 interactions	EHBP1 TET2 GAPVD1 ZBTB2 ZGRF1 DVL2 GPAM ZNF318 PRDM4 ZBTB1 JMJD1C DDIT3 RNF157 ZFPM2 ALMS1 BRCA1 UBR5 SYNE2 ANKRD17 TAF1 CRYBG3 LRBA STAG2 PPP6R3	1.67e-05	1108	168	24	int:HDAC1
Interaction	GOLGA1 interactions	GAPVD1 ERCC6L DVL2 CEP192 ALMS1 MACF1 GCC1 CRYBG3 AHNAK2	2.36e-05	183	168	9	int:GOLGA1
Interaction	GUSBP5 interactions	DVL2 ZNF318 WDR59 ALMS1 CEP295 CHD6	3.84e-05	75	168	6	int:GUSBP5
Interaction	DHX40 interactions	ERCC5 ESS2 NSD1 ZNF318 ZFC3H1 NOP14 BRCA1 UBR5 TAF1 NOL8	4.72e-05	249	168	10	int:DHX40
Interaction	POLR1G interactions	NAA15 BICRA POLR2E NSD1 ZFC3H1 MORC2 DNTTIP2 KAT7 NOP14 PHF3 SGO2 TAF1 STAG2 NOL8	6.33e-05	489	168	14	int:POLR1G
Interaction	CFAP184 interactions	ESS2 ANK3 ERCC6L ZNF318 ALMS1 CEP295 WDR62 BORA	6.56e-05	162	168	8	int:CFAP184
Interaction	NAA40 interactions	EHBP1 GAPVD1 NAA15 ANK2 ERCC6L DVL2 TACC2 ZNF318 DNTTIP2 CEP170 ALMS1 AP2B1 TJP1 ANKRD17 MACF1 LRBA EPB41 WDR62 PPP6R3 AHNAK2 NOL8	6.69e-05	978	168	21	int:NAA40
Interaction	RCOR1 interactions	EHBP1 ZGRF1 DVL2 ZNF318 ZBTB1 JMJD1C ALMS1 UBR5 ANKRD17 CHD6 TAF1 LRBA WDR62 PPP6R3	7.05e-05	494	168	14	int:RCOR1
Interaction	RYK interactions	ANK3 PCDHGB5 TMEM59 FAM171A1 CNNM1 CELSR2 PTPRK ALCAM FGFR4	7.43e-05	212	168	9	int:RYK
Interaction	KDM1A interactions	EHBP1 TET2 GAPVD1 ZGRF1 DVL2 ZNF318 ZBTB1 JMJD1C NOL4L ALMS1 BRCA1 UBR5 ANKRD17 GCC1 CHD6 TAF1 CRYBG3 LRBA WDR62 PPP6R3	1.16e-04	941	168	20	int:KDM1A
Interaction	CTDSPL interactions	ANK3 FAM171A1 PTPN14 TIAM1 TJP1 ADGRL2	1.21e-04	92	168	6	int:CTDSPL
Interaction	OTUD7A interactions	ANK2 ANK3 TJP1 MACF1 ADGRL3	1.22e-04	58	168	5	int:OTUD7A
Interaction	SIRT7 interactions	GAPVD1 NAA15 INTS1 NSD1 ZNF318 DNTTIP2 CEP170 NOP14 AP2B1 UBR5 TJP1 PHF3 SYNE2 ANKRD17 MACF1 STAG2 PPP6R3	1.66e-04	744	168	17	int:SIRT7
GeneFamily	Variable charge X/Y family	VCX3A VCX3B VCY	5.08e-06	6	116	3	368
GeneFamily	Adhesion G protein-coupled receptors, subfamily L	ADGRL2 ADGRL3	2.43e-04	4	116	2	918
GeneFamily	PDZ domain containing	DVL2 PDZD7 SHROOM2 TIAM1 TJP1 AHNAK2	4.44e-04	152	116	6	1220
GeneFamily	WD repeat domain containing\|BEACH domain containing	LYST LRBA	1.43e-03	9	116	2	1230
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	EHBP1 GAPVD1 MYO10 CEP170 FAM171A1 EFNA5 BRCA1 TIAM1 PTPRK UBR5 PHF3 SYNE2 SERPINE1 ANKRD17 MACF1 ALCAM CRYBG3 DMD SUCO STAG2	1.05e-06	856	173	20	M4500
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	CACNA1A BDP1 PSD2 ANK2 ANK3 SYTL2 PDZD7 ZNF318 SHROOM2 LYST RNF157 ZFPM2 FRY NOL4L EFNA5 NRXN2 PTPRK ASXL3 ANKRD12 EPB41 ADGRL3 AHNAK2 CCSER1	1.14e-06	1106	173	23	M39071
Coexpression	GSE27786_LIN_NEG_VS_BCELL_UP	SPATA7 INTS1 FAM171A1 PTPN14 SGO2 ADGRL2 EPB41 WDR62 BORA	7.72e-06	200	173	9	M4766
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	TET2 MYO10 KAT7 CNNM1 PRDM10 BRCA1 CELSR2 MACF1	2.73e-05	180	173	8	M8239
Coexpression	LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX	ANK3 MYO10 SYTL2 NAALADL2 TRPM3 LRBA CCSER1	4.35e-05	141	173	7	M39235
Coexpression	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP	CYP2C9 PCNX2 FRY HPN SERPINE1 MACF1 ALCAM ZC3H12C IL1A WNK4 EPB41 ADGRL3	4.98e-05	452	173	12	M18685
Coexpression	GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_UP	ANK3 ZFC3H1 MORC2 WDR59 FRY FAM13A LTBP3 CRYBG3	5.76e-05	200	173	8	M9883
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML5	PSD2 LRCH2 ANK2 ANK3 SYTL2 PDZD7 ZFPM2 FRY NRXN2 ASXL3 ZC3H12C EPB41	6.53e-05	465	173	12	M39066
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	EHBP1 GAPVD1 MYO10 CEP170 FAM171A1 BRCA1 TIAM1 PTPRK UBR5 PHF3 SERPINE1 ANKRD17	6.67e-05	466	173	12	M13522
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBGABA	CACNA1A BDP1 PSD2 ANK2 ANK3 SYTL2 PDZD7 SHROOM2 TMEM129 FRY NRXN2 PTPRK ASXL3 ANKRD12 CCSER1	7.02e-05	703	173	15	M39070
Coexpression	LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE	ANK3 NAALADL2 FREM1 EFNA5 NHS LRBA ADGRL2 CCSER1	7.58e-05	208	173	8	M39233
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	CACNA1A BDP1 SORBS2 ANK2 ADAMTS2 MYO10 FANCM DNTTIP2 PDPN ALMS1 BRCA1 CELSR2 NRXN2 RTL3 UBR5 RTL1 SYNE2 NHS CHD6 ZC3H12C LRBA DMD EPB41 NOL8 CCSER1	2.73e-07	983	169	25	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	CACNA1A MYO10 KIAA0586 ALMS1 BRCA1 CELSR2 NRXN2 TJP1 SYNE2 NHS ZC3H12C DMD EPB41	8.20e-07	298	169	13	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	CACNA1A MYO10 DNTTIP2 ALMS1 BRCA1 CELSR2 NRXN2 UBR5 SYNE2 ZC3H12C DMD NOL8	1.32e-05	328	169	12	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	CACNA1A MYO10 DNTTIP2 ALMS1 BRCA1 CELSR2 NRXN2 UBR5 STARD9 SYNE2 NHS CHD6 ANKRD12 ALCAM ZC3H12C DMD NOL8	1.94e-05	654	169	17	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	BDP1 CEP192 FANCM ZBTB1 DNTTIP2 NOP14 ALMS1 BRCA1 UBR5 TJP1 PHF3 SGO2 ZC3H12C EPB41 NOL8	2.42e-05	532	169	15	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000	ERCC6L ZGRF1 ZNF318 CEP192 TEX14 HORMAD1 LYST PDPN NOP14 ALMS1 BRCA1 CARF PRMT9 SGO2 CEP295 ANKRD12 TAF1 LRBA NOL8	3.03e-05	820	169	19	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	SPATA7 CACNA1A BDP1 SORBS2 NAA15 MYO10 KIAA0586 DVL2 DMBX1 ALMS1 BRCA1 CELSR2 NRXN2 UBR5 SYNE2 CEP295 ZC3H12C LRBA DMD WDR62 NOL8	4.07e-05	989	169	21	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500	BDP1 SORBS2 MYO10 DMBX1 ALMS1 BRCA1 CELSR2 NRXN2 UBR5 SYNE2 CEP295 ZC3H12C WDR62 NOL8	4.71e-05	498	169	14	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	BDP1 ERCC5 LRCH2 ANK2 ERCC6L MYO10 ZGRF1 KIAA0586 NSD1 CEP192 FANCM DNTTIP2 ALMS1 BRCA1 PHF3 SYNE2 MACF1 SGO2 CEP295 DMD EPB41 NOL8 BORA CCSER1	6.04e-05	1257	169	24	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	SPATA7 BDP1 ZBTB2 CEP192 FANCM DNTTIP2 NOP14 ALMS1 TJP1 SGO2 EPB41 NOL8 BORA	1.02e-04	469	169	13	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	TET2 ADAMTS2 ERCC6L MYO10 CYP17A1 GPAM FREM1 ZFPM2 PDPN EFNA5 TIAM1 STARD9 ASXL3 SYNE2 ALCAM ADGRL2 ADGRL3	1.41e-04	768	169	17	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000	BDP1 SORBS2 ANK3 SPINT1 MYO10 MYNN MFAP3L FAM171A1 EFNA5 CELSR2 PHF3 HPN FGFR4 LRBA SUCO WNK4 CCSER1	1.54e-04	774	169	17	gudmap_developingKidney_e15.5_cortic collect duct_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	EHBP1 TET2 ADAMTS2 ZGRF1 CYP17A1 SYTL2 GPAM CEP192 FREM1 ZFPM2 EFNA5 ASXL3 NHS SGO2 MYOCD ALCAM ADGRL3	1.62e-04	777	169	17	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	GAPVD1 SORBS2 NAA15 ADAMTS2 CYP17A1 JMJD1C KAT7 PTPRK RTL3 STARD9 ASXL3 SYNE2 MYOCD CEP295 ANKRD12 CAVIN2 AHNAK2	1.97e-04	790	169	17	gudmap_developingGonad_e16.5_epididymis_1000
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	SORBS2 ANK2 ANK3 TACC2 FRY EFNA5 XIRP2 SPHKAP MYOCD DMD CCSER1	1.57e-10	185	171	11	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 MYO10 SNRK NAALADL2 FREM1 FAM171A1 FRY PTPN14 ANKRD17 LRBA CCSER1	1.97e-10	189	171	11	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	SORBS2 ANK3 JMJD1C PTPRK TRPM3 SYNE2 ANKRD17 NHS MACF1 LRBA CCSER1	2.33e-10	192	171	11	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	SORBS2 ANK2 ANK3 TACC2 FRY EFNA5 XIRP2 SPHKAP MYOCD DMD CCSER1	2.75e-10	195	171	11	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	TET2 MYO10 SYTL2 ZFPM2 FRY TRPM3 XIRP2 NHS ALCAM CRYBG3	2.00e-09	179	171	10	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	SORBS2 ANK2 ANK3 TACC2 FRY EFNA5 XIRP2 MYOCD DMD CCSER1	2.61e-09	184	171	10	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	SORBS2 ANK2 ANK3 TACC2 FRY EFNA5 SPHKAP MYOCD ADGRL2 CCSER1	3.38e-09	189	171	10	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	SORBS2 ANK2 TACC2 EFNA5 XIRP2 SPHKAP MYOCD DMD ADGRL2 CCSER1	3.38e-09	189	171	10	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	SORBS2 ANK2 ANK3 TACC2 EFNA5 SPHKAP MYOCD DMD ADGRL2 CCSER1	3.56e-09	190	171	10	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	SORBS2 ANK2 ANK3 TACC2 ZFPM2 EFNA5 SPHKAP DMD ADGRL2 CCSER1	3.74e-09	191	171	10	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	SORBS2 ANK2 ANK3 TACC2 FRY EFNA5 SPHKAP MYOCD ADGRL2 CCSER1	3.94e-09	192	171	10	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	SORBS2 ANK2 ANK3 TACC2 FRY EFNA5 XIRP2 MYOCD DMD CCSER1	4.14e-09	193	171	10	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	SORBS2 ANK2 ANK3 TACC2 FRY EFNA5 MYOCD DMD ADGRL2 CCSER1	4.35e-09	194	171	10	c3535f7cc0076653c72db582047cff053c322397
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	TPO SNRK SHROOM2 ZFPM2 FRY TJP1 STARD9 SYNE2 SERPINE1 ADGRL2	4.80e-09	196	171	10	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BDP1 ANK3 SYTL2 ZFC3H1 PHF3 SYNE2 MACF1 ANKRD12 LRBA EPB41	5.55e-09	199	171	10	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TET2 BDP1 DDX60 ZFC3H1 JMJD1C PHF3 SYNE2 MACF1 ANKRD12 EPB41	5.82e-09	200	171	10	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	SORBS2 ANK3 TACC2 FRY EFNA5 XIRP2 MYOCD DMD CCSER1	3.77e-08	182	171	9	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SORBS2 ANK2 TACC2 FRY EFNA5 XIRP2 SPHKAP MYOCD DMD	4.34e-08	185	171	9	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	SORBS2 ANK2 ANK3 TACC2 EFNA5 XIRP2 MYOCD DMD CCSER1	5.21e-08	189	171	9	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	SORBS2 ANK2 ANK3 TACC2 SPHKAP MYOCD DMD ADGRL2 CCSER1	5.71e-08	191	171	9	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	COVID-19-kidney-CNT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANK3 SYTL2 NAALADL2 FREM1 FAM171A1 EFNA5 TRPM3 NHS CCSER1	5.97e-08	192	171	9	760c6b9628de9693034b00c5025c5c4df94bb2e8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 TACC2 NAALADL2 EFNA5 TRPM3 HPN NHS LRBA CCSER1	6.24e-08	193	171	9	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	EHBP1 BDP1 ZFC3H1 WDR59 UBR5 PHF3 CHD6 LRBA PPP6R3	6.24e-08	193	171	9	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial-suprabasal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPINT1 MYO10 THOP1 EFNA5 CELSR2 SYNE2 ANKRD12 ADGRL2 WDR62	6.52e-08	194	171	9	a3adcdc8b87332e8beb9bcd70cf36424af10633d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC3 ANK3 TACC2 NAALADL2 FREM1 NOL4L EFNA5 LRBA CCSER1	6.52e-08	194	171	9	04bfc555743f7d8821439d05ae442d15e9886c59
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SNRK ZFPM2 FAM171A1 PTPRK TJP1 MACF1 ADGRL2 ADGRL3 CCSER1	6.52e-08	194	171	9	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	SORBS2 ANK2 ANK3 TACC2 EFNA5 SPHKAP MYOCD DMD CCSER1	6.81e-08	195	171	9	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 NAALADL2 FAM171A1 PTPN14 EFNA5 HPN NHS LRBA CCSER1	6.81e-08	195	171	9	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ABCC3 MYO10 NAALADL2 FREM1 ASXL3 SPHKAP MACF1 FGFR4 ADGRL2	7.44e-08	197	171	9	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	LV-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	CACNA1A SORBS2 SYTL2 FRY ACAN NHS MYOCD DMD	2.55e-07	165	171	8	f37fd95adc95d7753cf6e55ae819976513c7ec77
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NAALADL2 FREM1 FAM171A1 EFNA5 LRBA ADGRL2 WNK4 CCSER1	5.38e-07	182	171	8	5f513bbb7125956eb528e3120de3fd776770a7c3
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LRCH2 ZFPM2 PDPN PTPN14 EFNA5 SPHKAP MACF1 CAVIN2	6.35e-07	186	171	8	20340a5b5cc7f07386498a4ef937d6fbc9e347c4
ToppCell	human_hepatoblastoma-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	SORBS2 GPAM LYST WDR59 PTPRK HPN LRBA DMD	6.61e-07	187	171	8	f3e37c18ac6471c7992609bbddfa4975571c815c
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	SORBS2 TACC2 EFNA5 XIRP2 SPHKAP MYOCD ADGRL2 CCSER1	6.61e-07	187	171	8	78cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	SORBS2 ANK2 ANK3 TACC2 MYOCD DMD ADGRL2 CCSER1	6.88e-07	188	171	8	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	SORBS2 TACC2 EFNA5 XIRP2 SPHKAP MYOCD ADGRL2 CCSER1	6.88e-07	188	171	8	0758b474457efa36488e0195f7357100f4b6a090
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	SYTL2 FRY SERPINE1 NHS MACF1 MYOCD DMD ADGRL3	7.16e-07	189	171	8	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	SORBS2 ANK2 ANK3 TACC2 XIRP2 MYOCD DMD CCSER1	7.45e-07	190	171	8	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	SORBS2 ANK2 TACC2 EFNA5 SPHKAP DMD ADGRL2 CCSER1	7.45e-07	190	171	8	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TPO ANK2 ZFPM2 FRY XIRP2 SPHKAP MYOCD DMD	7.45e-07	190	171	8	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYTL2 NAALADL2 FREM1 FAM171A1 FRY EFNA5 ASXL3 CCSER1	7.45e-07	190	171	8	4836ea19308d2a96694f12ab0653b7ce7b101d2f
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	ANK3 SPINT1 NAALADL2 FER1L6 EFNA5 NHS ALCAM CCSER1	7.45e-07	190	171	8	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	EHBP1 BDP1 ZFC3H1 WDR59 PTPRK UBR5 PHF3 CHD6	8.06e-07	192	171	8	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DDX60 SNRK FAM171A1 TJP1 ZC3H12C ADGRL2 ADGRL3 CAVIN2	8.06e-07	192	171	8	c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCell	human_hepatoblastoma-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ZGRF1 CEP192 FANCM BRCA1 SGO2 CEP295 WDR62 BORA	8.38e-07	193	171	8	4b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCell	COVID-19-kidney-CD-PC\|kidney / Disease (COVID-19 only), tissue and cell type	ANK3 SYTL2 NAALADL2 FREM1 FAM171A1 FRY TRPM3 CCSER1	8.38e-07	193	171	8	738689d009e4b118d7ce3171a207294b95cbe78b
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BDP1 MYO10 NSD1 SNRK MACF1 ANKRD12 SUCO CAVIN2	8.72e-07	194	171	8	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	Fibroblasts-Pericytes\|Fibroblasts / lung cells shred on cell class, cell subclass, sample id	SORBS2 SYTL2 FRY ACAN SYNE2 MYOCD DMD ADGRL3	9.06e-07	195	171	8	c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1
ToppCell	wk_20-22-Epithelial-Distal_epithelial-type_I_pneumocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	SPINT1 FREM3 PDPN CELSR2 HPN ALCAM DMD CAVIN2	9.42e-07	196	171	8	e24a7aaf41793abba66c1189d933ca05b14c1af9
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 SNRK FAM171A1 TJP1 MACF1 IL1A ADGRL2 CAVIN2	9.78e-07	197	171	8	deefb492b5f0e6014144bd465c4a6ae4206e8739
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC3 ANK3 SYTL2 NAALADL2 EFNA5 SYNE2 NHS CCSER1	9.78e-07	197	171	8	7e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ANK3 SYTL2 ZFC3H1 SYNE2 MACF1 ANKRD12 LRBA EPB41	9.78e-07	197	171	8	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 SNRK FAM171A1 TJP1 MACF1 IL1A ADGRL2 CAVIN2	9.78e-07	197	171	8	a6aaa6faea348291023f0bc4b0f83fbc67d91da6
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 SNRK FAM171A1 TJP1 MACF1 IL1A ADGRL2 CAVIN2	1.02e-06	198	171	8	f0f1816a0ed3ae8207442602f5cbe4de0382e4b3
ToppCell	mild-CD4+_Tcm\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ANK3 DDX60 TNFRSF4 PHF3 SYNE2 MACF1 ANKRD12 EPB41	1.06e-06	199	171	8	06c8a0e39f7a33736548f04a5e2263334c8541cf
ToppCell	mild-MAIT\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BDP1 DDX60 SYTL2 ZBTB1 PHF3 SYNE2 MACF1 EPB41	1.06e-06	199	171	8	cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	ANK3 NAALADL2 EFNA5 UBR5 LRBA DMD PPP6R3 CCSER1	1.06e-06	199	171	8	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ANK3 SYTL2 KCNG2 NRXN2 SPHKAP MYOCD LTBP3 DMD	1.06e-06	199	171	8	6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SNRK FAM171A1 TJP1 SYNE2 MACF1 ADGRL2 ADGRL3 CAVIN2	1.10e-06	200	171	8	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SNRK FAM171A1 UBR5 TJP1 SYNE2 MACF1 ADGRL2 ADGRL3	1.10e-06	200	171	8	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SNRK FAM171A1 TJP1 SYNE2 MACF1 ADGRL2 ADGRL3 CAVIN2	1.10e-06	200	171	8	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SORBS2 ANK3 TACC2 NAALADL2 EFNA5 PTPRK ALCAM CCSER1	1.10e-06	200	171	8	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SNRK FAM171A1 TJP1 SYNE2 MACF1 ADGRL3 CAVIN2 CCSER1	1.10e-06	200	171	8	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SORBS2 ANK3 SPINT1 PTPRK TJP1 SYNE2 ALCAM AHNAK2	1.10e-06	200	171	8	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	LA-06._Ventricular_Cardiomyocyte_II\|LA / Chamber and Cluster_Paper	SORBS2 PDZD7 HORMAD1 GCC1 DMD CCSER1	1.50e-06	92	171	6	fad2e02ae858e3a9bbe51ad1c689f7e31d11ce0e
ToppCell	LA-15._Ventricular_Cardiomyocyte_III\|LA / Chamber and Cluster_Paper	SORBS2 ANK3 TACC2 DNAAF3 CNNM1 XIRP2 DMD	1.65e-06	147	171	7	8970eb6b82589f39439c61a57d999661ec8342de
ToppCell	E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor\|E16.5-samps / Age Group, Lineage, Cell class and subclass	ANK3 RBPJL SYTL2 TEX14 HORMAD1 SNX7 ALCAM	2.35e-06	155	171	7	9cad73d0b8ead289e1073d1a2e00bbeb1228308c
ToppCell	COPD-Lymphoid-ILC_B\|Lymphoid / Disease state, Lineage and Cell class	PSD2 TNFRSF4 FRY NOL4L TIAM1 HPN PRMT9	3.70e-06	166	171	7	e2cad1db536d5ad5a34c337c19b5e7d1a2851552
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	ANK3 TACC2 PTPN14 TJP1 SERPINE1 ALCAM ADGRL2	4.33e-06	170	171	7	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3\|GI_small-bowel / Manually curated celltypes from each tissue	ZFPM2 TNFRSF4 DNAAF3 CNNM1 FRY TIAM1 SERPINE1	4.33e-06	170	171	7	97df5ffb328196c46568975d2d97722bcc753bf5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NAALADL2 FREM1 FAM171A1 EFNA5 LRBA WNK4 CCSER1	5.23e-06	175	171	7	e5467dacf81f1f913b1719931cf1a7331434a7e7
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NSD1 LYST JMJD1C XIRP2 MACF1 MYOCD DMD	5.43e-06	176	171	7	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	LPS-IL1RA+antiTNF\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SORBS2 FREM1 FAM13A TRPM3 PHF3 LRBA CAVIN2	5.64e-06	177	171	7	b7fee75de7e96924af488a5baa2334711889ae7c
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LRCH2 ZFPM2 PDPN PTPN14 EFNA5 MACF1 CAVIN2	5.85e-06	178	171	7	ad3de3e03a401dac64431a541899445262246347
ToppCell	BAL-Mild-cDC_4\|Mild / Compartment, Disease Groups and Clusters	ZBTB2 CEP192 FANCM ELL3 STARD9 SYNE2 CARF	6.07e-06	179	171	7	68511e87b12b8253de7771e5ccfc5869248b8450
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NAALADL2 FREM1 FAM171A1 EFNA5 ADGRL2 WNK4 CCSER1	6.07e-06	179	171	7	666072c0e8448dbaec1683d18368ec2502453f90
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 SYTL2 FREM1 FRY ASXL3 ADGRL2 CCSER1	6.07e-06	179	171	7	d3438fed0d85d5ed5afa8ff820c45143d77b6c0d
ToppCell	MatrixFB-Fibroblast-A\|MatrixFB / shred on cell class and cell subclass (v4)	MYO10 FREM1 FAM171A1 MACF1 ALCAM FGFR4 CAVIN2	6.30e-06	180	171	7	adc64ad6033af705dd7b9163a83e20ef5c59f6eb
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SNRK FAM171A1 TJP1 ZC3H12C ADGRL2 ADGRL3 CAVIN2	6.30e-06	180	171	7	30cf3c7ee29694eaccb89bf8053a82037d5c9f1d
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SORBS2 ANK2 FRY XIRP2 SPHKAP MYOCD DMD	6.53e-06	181	171	7	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	ANK3 JMJD1C UBR5 SYNE2 MACF1 ANKRD12 LRBA	6.53e-06	181	171	7	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANK3 TSPYL1 TNFRSF4 NOL4L TIAM1 SYNE2 EPB41	6.77e-06	182	171	7	9ba85f621a846531a2a7861e9df695d288c9e149
ToppCell	droplet-Marrow-nan-3m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYTL2 NSD1 DRC1 LYST MACF1 SUCO STAG2	6.77e-06	182	171	7	e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCell	droplet-Marrow-nan-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYTL2 NSD1 DRC1 LYST MACF1 SUCO STAG2	6.77e-06	182	171	7	1710eab3037a87609d21838be2d2d29c3bc36651
ToppCell	pdx-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	MYO10 SYTL2 ZFPM2 TRPM3 NHS ALCAM CRYBG3	6.77e-06	182	171	7	7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	CACNA1A SYTL2 FRY NHS MYOCD DMD ADGRL3	7.02e-06	183	171	7	818fd886e0188091310825f9145fa53328f2c979
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ANK2 NAALADL2 FAM171A1 EFNA5 LRBA WNK4 CCSER1	7.02e-06	183	171	7	31ab55d5f3639f5964541d5eae23044dbda3356e
ToppCell	IPF-Lymphoid-ILC_B\|Lymphoid / Disease state, Lineage and Cell class	NAALADL2 TNFRSF4 FRY NOL4L TIAM1 HPN PRMT9	7.02e-06	183	171	7	9b507547e6adf78e46e7f542cd9958224ec5826a
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FREM1 TRPM3 XIRP2 ASXL3 MYOCD DMD ADGRL3	7.27e-06	184	171	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	SORBS2 ANK3 TACC2 EFNA5 PTPRK HPN CCSER1	7.27e-06	184	171	7	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FREM1 TRPM3 XIRP2 ASXL3 MYOCD DMD ADGRL3	7.27e-06	184	171	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FREM1 TRPM3 XIRP2 ASXL3 MYOCD DMD ADGRL3	7.27e-06	184	171	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 ZFPM2 EFNA5 SPHKAP MYOCD DMD AHNAK2	7.53e-06	185	171	7	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ANK2 NAALADL2 FAM171A1 EFNA5 LRBA WNK4 CCSER1	7.53e-06	185	171	7	898a093757f86be3e18d2ef1f16a71f50ef81dc3
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANK2 NAALADL2 EFNA5 HPN LRBA WNK4 CCSER1	7.80e-06	186	171	7	1850583d23903d08226aeb0edb3e07b0994330e4
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 NSD1 LYST PTPN14 TJP1 SYNE2 CAVIN2	7.80e-06	186	171	7	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANK2 NAALADL2 EFNA5 HPN LRBA WNK4 CCSER1	7.80e-06	186	171	7	4dafc215c42e7949f932a3627359c107943b5d6b
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EHBP1 ABCC3 SORBS2 ANK3 PTPRK SYNE2 NHS	7.80e-06	186	171	7	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SORBS2 FAM171A1 FRY PTPN14 TJP1 ADGRL2 CAVIN2	8.08e-06	187	171	7	3548a9914c2b2f5d805798ce22ab26eab6d03897
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SORBS2 FAM171A1 FRY PTPN14 TJP1 ADGRL2 CAVIN2	8.08e-06	187	171	7	f4de4b7af1fdfbd628b1f509c060c1079d2e5437
Computational	Genes upregulated in subsets of cells of a given type within various tumors	BDP1 NOP14 TJP1 PHF3 SYNE2 MACF1	7.98e-06	50	104	6	GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN
Disease	Intellectual Disability	NAA15 TTI2 NSD1 FRY BRCA1 NRXN2 TRPM3 DHPS NXF5 PACS2 MACF1 TAF1 STAG2 WDR62	2.66e-07	447	166	14	C3714756
Disease	cleft lip	EHBP1 NSD1 CCDC168 ZNF318 NAALADL2 WDR59 FRY BRCA1 FGFR4	3.54e-05	284	166	9	EFO_0003959
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	TET2 GAPVD1 SNRK TACC2 DNAAF3 KCNG2 EFNA5 ALMS1 FAM13A NRXN2 PTPRK ZNF75A ALCAM ADGRL2 ADGRL3	5.05e-05	801	166	15	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	femoral neck bone geometry	NSD1 FGFR4 PPP6R3	6.08e-05	14	166	3	EFO_0004511
Disease	short-term memory	SORBS2 C6orf118 PTPRK IL1A ADGRL3	1.08e-04	83	166	5	EFO_0004335
Disease	Global developmental delay	INTS1 TRPM3 DHPS PACS2 TAF1 STAG2	1.10e-04	133	166	6	C0557874
Disease	neutrophil-activating peptide 2 measurement	JMJD1C ZFPM2	1.87e-04	4	166	2	EFO_0020606
Disease	congenital diaphragmatic hernia (is_implicated_in)	FREM1 ZFPM2	1.87e-04	4	166	2	DOID:3827 (is_implicated_in)
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	GPAM JMJD1C CELSR2 SYNE2 MACF1 LRBA	2.12e-04	150	166	6	EFO_0004611, EFO_0020947
Disease	severe acute respiratory syndrome, COVID-19	ABCC3 DRC1 LYST ZFPM2 DNAAF3 EFNA5 LTBP3 ALCAM DMD ADGRL3	2.34e-04	447	166	10	EFO_0000694, MONDO_0100096
Disease	unipolar depression, bipolar disorder	ANK3 C6orf118 EFNA5 STARD9 ASXL3 SYNE2	2.62e-04	156	166	6	EFO_0003761, MONDO_0004985
Disease	smoking status measurement	GAPVD1 BICRA SNRK PDZD7 DMBX1 DNAAF3 KCNG2 NOL4L C6orf118 EFNA5 ALMS1 NRXN2 PTPRK SERPINE1 ZNF75A CEP295 CCSER1	3.07e-04	1160	166	17	EFO_0006527
Disease	Abnormality of head or neck	DHPS STAG2	3.11e-04	5	166	2	C4021817
Disease	immature platelet count	JMJD1C ZFPM2 AP2B1 TRPM3 CAVIN2	3.40e-04	106	166	5	EFO_0803544
Disease	mental development measurement	PCDHGB5 PCDHGB3 PCDHGA8	3.67e-04	25	166	3	EFO_0008230
Disease	gamma-enolase measurement	JMJD1C ZFPM2	4.65e-04	6	166	2	EFO_0021845
Disease	hearing loss	DVL2 ZNF318 PTPRK ACAN	5.62e-04	67	166	4	EFO_0004238
Disease	MYELODYSPLASTIC SYNDROME	TET2 FANCM BRCA1 STAG2	5.62e-04	67	166	4	C3463824
Disease	immature platelet measurement	JMJD1C ZFPM2 AP2B1 TRPM3 CAVIN2	5.78e-04	119	166	5	EFO_0803541
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	GPAM JMJD1C CELSR2 SYNE2 MACF1	6.24e-04	121	166	5	EFO_0008595, EFO_0020943
Disease	childhood trauma measurement, alcohol consumption measurement	PCDHGB5 PCDHGB3 MYOCD PCDHGA8	7.00e-04	71	166	4	EFO_0007878, EFO_0007979
Disease	stomach cancer (is_implicated_in)	TET2 ERCC5 BRCA1 FGFR4	7.38e-04	72	166	4	DOID:10534 (is_implicated_in)
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	GPAM JMJD1C CELSR2 SYNE2 MACF1	7.76e-04	127	166	5	EFO_0008595, EFO_0020947
Disease	body weight	EHBP1 TET2 GAPVD1 CEP192 PRDM4 WDR59 NOL4L PTPN14 RTL3 PHF3 ACAN ASXL3 SPHKAP LTBP3 FGFR4 DMD CCSER1	7.86e-04	1261	166	17	EFO_0004338
Disease	free cholesterol to total lipids in large LDL percentage	GPAM JMJD1C CELSR2 MACF1	8.18e-04	74	166	4	EFO_0022280
Disease	X-11787 measurement	CYP2C9 ALMS1	8.61e-04	8	166	2	EFO_0021258
Disease	Dickkopf-related protein 4 measurement	JMJD1C ZFPM2	8.61e-04	8	166	2	EFO_0008110
Disease	pain	NSD1 CEP170 NOL4L NOP14 CELSR2 MACF1	8.76e-04	196	166	6	EFO_0003843
Disease	testosterone measurement	TET2 DCHS2 ANK2 ANK3 ERCC6L CYP17A1 GPAM ZNF318 JMJD1C ZFPM2 THOP1 HPN SYNE2 MACF1 MYOCD TMEM102 ADGRL2	8.87e-04	1275	166	17	EFO_0004908
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	GPAM JMJD1C CELSR2 ASXL3 SYNE2 MACF1	9.72e-04	200	166	6	EFO_0004611, EFO_0020945
Disease	Kartagener Syndrome	DRC1 DNAAF3 LRRC56	1.00e-03	35	166	3	C0022521
Disease	Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus	DRC1 DNAAF3 LRRC56	1.00e-03	35	166	3	C4551906
Disease	Polynesian Bronchiectasis	DRC1 DNAAF3 LRRC56	1.00e-03	35	166	3	C4317124
Disease	vascular endothelial growth factor A, isoform 121 measurement	JMJD1C ZFPM2	1.10e-03	9	166	2	EFO_0020847
Disease	Malignant neoplasm of breast	EHBP1 ANK2 CYP17A1 TACC2 ZNF318 SHROOM2 DDIT3 PTPN14 BRCA1 SYNE2 NHS ZNF75A MACF1 LRBA DMD	1.13e-03	1074	166	15	C0006142
Disease	Profound Mental Retardation	NAA15 TTI2 NSD1 FRY WDR62	1.16e-03	139	166	5	C0020796
Disease	lung non-small cell carcinoma (is_implicated_in)	TET2 ERCC5 BRCA1 FGFR4 IL1A	1.16e-03	139	166	5	DOID:3908 (is_implicated_in)
Disease	Mental Retardation, Psychosocial	NAA15 TTI2 NSD1 FRY WDR62	1.16e-03	139	166	5	C0025363
Disease	Mental deficiency	NAA15 TTI2 NSD1 FRY WDR62	1.16e-03	139	166	5	C0917816
Disease	metabolite measurement	ABCC3 CYP2C9 ANK3 GPAM SHROOM2 ALMS1 SYNE2 ALCAM DMD PPP6R3	1.33e-03	560	166	10	EFO_0004725
Disease	interstitial lung disease (is_implicated_in)	SERPINE1 IL1A	1.37e-03	10	166	2	DOID:3082 (is_implicated_in)
Disease	CXCL5 measurement	JMJD1C ZFPM2	1.37e-03	10	166	2	EFO_0009422
Disease	C-X-C motif chemokine 5 measurement	JMJD1C ZFPM2	1.37e-03	10	166	2	EFO_0008058
Disease	cholelithiasis	NSD1 JMJD1C FGFR4 LRBA	1.56e-03	88	166	4	EFO_0004799
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	GPAM JMJD1C CELSR2 SYNE2 MACF1 LRBA	1.66e-03	222	166	6	EFO_0008317, EFO_0020943
Disease	glomerulonephritis (is_implicated_in)	TPO SERPINE1	1.67e-03	11	166	2	DOID:2921 (is_implicated_in)
Disease	N-acetylhistidine measurement	ALMS1 SERPINE1	1.67e-03	11	166	2	EFO_0800022
Disease	coffee consumption measurement, tea consumption measurement	TET2 HORMAD1 JMJD1C	1.96e-03	44	166	3	EFO_0006781, EFO_0010091
Disease	congenital diaphragmatic hernia (implicated_via_orthology)	FREM1 ZFPM2	2.00e-03	12	166	2	DOID:3827 (implicated_via_orthology)
Disease	vascular endothelial growth factor A measurement	JMJD1C ZFPM2	2.00e-03	12	166	2	EFO_0010804
Disease	polycystic ovary syndrome (is_marker_for)	CYP17A1 SERPINE1	2.00e-03	12	166	2	DOID:11612 (is_marker_for)
Disease	dickkopf‐related protein 1 measurement	JMJD1C ZFPM2	2.00e-03	12	166	2	EFO_0010620
Disease	PR interval	ZFPM2 DNAAF3 C6orf118 TRPM3 SYNE2 MACF1 MYOCD CHD6 ADGRL3	2.04e-03	495	166	9	EFO_0004462
Disease	childhood trauma measurement, smoking behaviour measurement	SORBS2 DNAAF3 CCSER1	2.09e-03	45	166	3	EFO_0005671, EFO_0007979
Disease	esophagus squamous cell carcinoma (is_implicated_in)	TET2 BRCA1 FGFR4	2.09e-03	45	166	3	DOID:3748 (is_implicated_in)
Disease	ovarian carcinoma	SORBS2 GPAM TACC2 BRCA1 TIAM1 ASXL3 DMD	2.35e-03	321	166	7	EFO_0001075
Disease	Graves ophthalmopathy (is_marker_for)	SERPINE1 IL1A	2.36e-03	13	166	2	DOID:0081120 (is_marker_for)
Disease	Primary Ciliary Dyskinesia	DRC1 DNAAF3 LRRC56	2.36e-03	47	166	3	C4551720
Disease	Adenoid Cystic Carcinoma	NSD1 JMJD1C BRCA1 FGFR4	2.49e-03	100	166	4	C0010606
Disease	frontal fibrosing alopecia	EHBP1 CACNA1A MYO10	2.51e-03	48	166	3	EFO_0009855
Disease	Prostatic Neoplasms	EHBP1 TET2 CYP17A1 BRCA1 PTPRK HPN SERPINE1 CHD6 FGFR4 NOL8	2.66e-03	616	166	10	C0033578
Disease	Malignant neoplasm of prostate	EHBP1 TET2 CYP17A1 BRCA1 PTPRK HPN SERPINE1 CHD6 FGFR4 NOL8	2.66e-03	616	166	10	C0376358
Disease	cholestasis (biomarker_via_orthology)	ABCC3 TJP1 IL1A	2.66e-03	49	166	3	DOID:13580 (biomarker_via_orthology)
Disease	birth weight, pelvic organ prolapse	NAALADL2 WDR59 ZFPM2	2.66e-03	49	166	3	EFO_0004344, EFO_0004710
Disease	inositol measurement	MYO10 TRPM3	2.74e-03	14	166	2	EFO_0010504
Disease	Kartagener syndrome (implicated_via_orthology)	DRC1 DNAAF3	2.74e-03	14	166	2	DOID:0050144 (implicated_via_orthology)
Disease	C-X-C motif chemokine 11 measurement	JMJD1C ZFPM2	2.74e-03	14	166	2	EFO_0008057
Disease	CD209 antigen measurement	CELSR2 STKLD1	2.74e-03	14	166	2	EFO_0008077
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	CELSR2 ANKRD17	2.74e-03	14	166	2	EFO_0004611, EFO_0008589
Disease	serum metabolite measurement	CDC42BPG SORBS2 CYP2C9 SNRK GPAM CCNYL3 PARP4 ALMS1 CELSR2 SYNE2 ALCAM PPP6R3 CCSER1	2.75e-03	945	166	13	EFO_0005653
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	GPAM JMJD1C SYNE2 MACF1	2.77e-03	103	166	4	EFO_0008595, EFO_0020944
Disease	cholesteryl esters to total lipids in IDL percentage	GPAM JMJD1C MACF1	2.82e-03	50	166	3	EFO_0022247
Disease	melanoma	ERCC5 GPAM CNNM1 PTPRK STAG2 EPB41	2.88e-03	248	166	6	C0025202
Disease	calcium measurement	TET2 ERCC5 ZNF318 ZFPM2 MFAP3L KAT7 CELSR2 HPN SYNE2 MACF1	3.05e-03	628	166	10	EFO_0004838
Disease	endometriosis	CACNA1A NAALADL2 KCNG2 NOL4L PTPN14 IL1A	3.12e-03	252	166	6	EFO_0001065
Disease	nasopharynx carcinoma (is_implicated_in)	TET2 BRCA1	3.15e-03	15	166	2	DOID:9261 (is_implicated_in)
Disease	DiGeorge Syndrome	ESS2 JMJD1C	3.58e-03	16	166	2	C0012236
Disease	interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement	JMJD1C ZFPM2	3.58e-03	16	166	2	EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293
Disease	focal segmental glomerulosclerosis	ALMS1 FGFR4	3.58e-03	16	166	2	EFO_0004236
Disease	CONOTRUNCAL ANOMALY FACE SYNDROME	ESS2 JMJD1C	3.58e-03	16	166	2	C0795907
Disease	pulmonary fibrosis (is_implicated_in)	SERPINE1 IL1A	3.58e-03	16	166	2	DOID:3770 (is_implicated_in)
Disease	Shprintzen syndrome	ESS2 JMJD1C	3.58e-03	16	166	2	C0220704
Disease	insomnia measurement	TET2 DNAAF3 NOL4L EFNA5 ALMS1 UBR5 ASXL3 CCSER1	3.73e-03	443	166	8	EFO_0007876
Disease	immature platelet fraction	JMJD1C ZFPM2 TRPM3 CAVIN2	3.99e-03	114	166	4	EFO_0009187
Disease	breast cancer (is_marker_for)	TET2 SPINT1 KAT7 BRCA1 SERPINE1	4.03e-03	185	166	5	DOID:1612 (is_marker_for)
Disease	1-Methylhistidine measurement	SORBS2 ALMS1	4.05e-03	17	166	2	EFO_0021543
Disease	sphingomyelin 14:0 measurement	TRPM3 SYNE2	4.05e-03	17	166	2	EFO_0010390
Disease	Fetal Alcohol Syndrome	ANK3 ERCC6L	4.05e-03	17	166	2	C0015923
Disease	idiopathic pulmonary fibrosis	ZNF318 PTPN14 FAM13A	4.10e-03	57	166	3	EFO_0000768
Disease	migraine disorder	CACNA1A NSD1 NOL4L TRPM3 CARF MACF1 DMD	4.21e-03	357	166	7	MONDO_0005277
Disease	reaction time measurement	TET2 ADAMTS2 DCP2 TACC2 CEP192 FAM171A1 EFNA5 PTPRK CHD6 ADGRL2	4.23e-03	658	166	10	EFO_0008393
Disease	cholesterol in IDL measurement	GPAM JMJD1C CELSR2	4.30e-03	58	166	3	EFO_0021899
Disease	chronotype measurement	ANK2 ANK3 ZNF318 TEX14 NOL4L C6orf118 EFNA5 AP2B1 NXF5 ALCAM ADGRL3 CCSER1	4.34e-03	882	166	12	EFO_0008328
Disease	colon cancer (is_marker_for)	BRCA1 UBR5 FGFR4	4.51e-03	59	166	3	DOID:219 (is_marker_for)
Disease	sphingosine 1-phosphate measurement	DNAAF3 DMD	4.54e-03	18	166	2	EFO_0800185
Disease	venous thromboembolism	DCHS2 ANK2 ANK3 NAALADL2 WDR59 ZFPM2 TRPM3 ADGRL2	4.66e-03	460	166	8	EFO_0004286
Disease	total lipids in IDL	GPAM JMJD1C CELSR2	4.73e-03	60	166	3	EFO_0022161
Disease	cholesterol to total lipids in IDL percentage	GPAM JMJD1C MACF1	4.73e-03	60	166	3	EFO_0022233
Disease	age at first birth measurement	CACNA1A TEX14 FREM1 NOL4L	4.79e-03	120	166	4	EFO_0009101
Disease	diastolic blood pressure, systolic blood pressure	GAPVD1 ANK2 ANK3 ALMS1 TRPM3 ACAN SERPINE1 MYOCD CHD6 WDR62	4.79e-03	670	166	10	EFO_0006335, EFO_0006336

Protein segments in the cluster

Peptide	Gene	Start	Entry
DLPVADDNTVHFNST	CACNA1A	1881	O00555
DLTDDDQTSSVPHSA	CEP170	1021	Q5SW79
DLHSLSSAETQPAQE	EPB41	146	P11171
EQTDTLPSQHDEASL	BDP1	1481	A6H8Y1
LEHSSSVQEDSESPS	ELL3	266	Q9HB65
LDDEHSLSTSPSEET	PRMT9	416	Q6P2P2
VAALSEISESHPNSN	AP2B1	181	P63010
THDSDSADESSDLPL	CXorf49;	201	A8MYA2
QTHPTEEQDSNSSEL	CRYBG3	181	Q68DQ2
LTSSNDDEDPKSHRD	FGFR4	121	P22455
TNEHTEDLQSPHRDS	ADGRL3	1341	Q9HAR2
SQQELPDSHLTEEAL	ALMS1	1951	Q8TCU4
TAEAEDHLQSPNRDS	ADGRL2	1356	O95490
SHSESNLPADSEREE	CCSER1	361	Q9C0I3
DQQHDPDTDSDSDLS	CELSR2	2711	Q9HCU4
DLPSSSEDQLLEHAE	DCP2	371	Q8IU60
NDSISPNESIDDEHL	DMD	3456	P11532
TQGLDDDTPLHDSAS	ANKRD12	246	Q6UB98
PAIDIDAQTESNHDT	ANKRD17	1071	O75179
DAQTESNHDTALTLA	ANKRD17	1076	O75179
SSSHENLEPETETES	DVL2	141	O14641
TDLSVHSSDENIPVS	ASXL3	1196	Q9C0F0
EVPLNASSTNATEDH	ADAMTS2	1141	O95450
PATDADALLESIHQE	RBPJL	491	Q9UBG7
SSDLDPIEHSSESDN	NSD1	646	Q96L73
PIEHSSESDNSVLEI	NSD1	651	Q96L73
IFSLTAHDPDSQENA	PCDHGA8	471	Q9Y5G5
DTLSNHTDLTDNDPV	ABCC3	881	O15438
DTSNFDVDDDTLNHP	CDC42BPG	361	Q6DT37
TENLDNVALSSSPIH	ANK2	951	Q01484
SENEEDSSSIDHLSL	IL1A	16	P01583
SDASTHQPVADALIE	FAM171A1	41	Q5VUB5
SESDIDISSPNVSHD	KAT7	136	O95251
ADSDASSLHEQPQQI	MFAP3L	301	O75121
HPSLTEEEDSQTELL	INTS1	286	Q8N201
EQSTVSDHNSNDLLP	JMJD1C	466	Q15652
PSITQLEDFLTEHNS	KIAA1109	11	Q2LD37
EENSLNSHPESLSLA	EDEM3	836	Q9BZQ6
HDVDNSDLPVLSTDQ	FANCM	1116	Q8IYD8
APVSEENEDSAHQIS	ZFPM2	281	Q8WW38
ESAHDSPRDEALQNI	GAPVD1	1081	Q14C86
PVDHEDISVSAQTLS	KCNQ4	671	P56696
LETPSDSEQLDSGHE	BNIPL	126	Q7Z465
DNHSALIEENPESTI	CARF	681	Q8N187
ELASSLHPAQDAEND	DDX60	706	Q8IY21
LPLHQEVDSSDSEVA	PCNX2	341	A6NKB5
LTLSDEDLTSVTQNH	PLXNB3	1586	Q9ULL4
EPALQEDSTHSATAT	KCNG2	426	Q9UJ96
NVDSLSALPETQHDF	NXF5	321	Q9H1B4
NSPIEANSDESDIIH	PDZD7	71	Q9H5P4
QSQHPTDALSEDLLS	TPO	111	P07202
NHLSATDPDTAADDL	FREM1	1046	Q5H8C1
DLSHNPIQSSTDEIT	NRXN2	301	Q9P2S2
SSAEDHTLSEQDSIQ	MYNN	531	Q9NPC7
INEESHFPQATDSTL	MYO10	506	Q9HD67
AATSATHELENIEPT	LRBA	1381	P50851
QSEDRVELDSQSPHD	LILRB3	521	O75022
QETQSSLEHEPETHT	PRDM10	466	Q9NQV6
EETDHRNSSPGEASL	NOL8	1091	Q76FK4
ENDNSPEVTFHSLLE	PCDHGB5	336	Q9Y5G0
NDNAPEITLASESQH	PCDHGB3	341	Q9Y5G1
EHFTPEATQLASEQL	PARP4	231	Q9UKK3
IASLSSQPIDHEDST	PACS2	171	Q86VP3
RSPQNLHSQEDDDSS	NOL4L	26	Q96MY1
EESDSPDSHLDLESN	NOP14	371	P78316
PDSHLDLESNVESEE	NOP14	376	P78316
RENSDSDEAHLSPQA	FAM13A	586	O94988
SLEALDPNVDEHLST	DRC1	6	Q96MC2
TDSDEHLEVLLNSQS	MYOCD	801	Q8IZQ8
NPLTDENKEHEADTA	NAA15	571	Q9BXJ9
SEENSNDIALVHLSS	HPN	251	P05981
ESHLDSELEISNDPD	MACF1	6571	Q9UPN3
ETSDHDNSLSVSIPQ	ACAN	21	P16112
PDTTALSTNHETIDL	MORC2	896	Q9Y6X9
LSIDVEDQNDHSPSF	DCHS2	1496	Q6V1P9
ENDAPHLESLETQAD	PRG3	21	Q9Y2Y8
EQQLEESGPHDLTET	BRCA1	1536	P38398
DNSTASQPDLRHTLE	CCNYL3	26	P0C7X3
LELPSAEHQAIESSQ	ESS2	196	Q96DF8
SPLDSHGEESSLDVN	GCC1	416	Q96CN9
SQADTVHSNPELDVL	DNAAF3	36	Q8N9W5
SINHDESLLPESLES	CHD6	1691	Q8TD26
PAELHLSLSEQSASE	DMBX1	176	Q8NFW5
PLSQDEDQHADLTQS	DHPS	76	P49366
ESPSDYSNLHEQTLA	BORA	26	Q6PGQ7
DQDSELLSDNHILTT	CYP17A1	281	P05093
IHVQSSSDSSDEPAE	FAM172A	211	Q8WUF8
YLNPQASLSHTSEED	C6orf118	131	Q5T5N4
DTILESPDDFSQHDQ	ANK3	2106	Q12955
ESDPDADRTTLNHAD	EHBP1	786	Q8NDI1
HDSENLTDSLQSPSA	LYST	2566	Q99698
ESSNAESAAPSQHLL	LTBP3	246	Q9NS15
EQTTQDIHPVDLSAT	CEP192	816	Q8TEP8
VENSLEPADDTVHES	EFNA5	181	P52803
HSPDSSQSSLAQEEE	DDIT3	81	P35638
HEDDLSSSINELPAA	FRY	2606	Q5TBA9
ESPDLSISHSQVEQL	HORMAD1	306	Q86X24
SESEDQVSPSSESHV	CCDC168	141	Q8NDH2
HNQPSEFTIESLENT	CYP2C9	276	P11712
SPQDDTLTEHLQSAI	BICRA	1491	Q9NZM4
ESHAENETKSEDLPS	CAVIN2	306	O95810
SQEESQHADLPSIFS	CEP295	2181	Q9C0D2
ETRDQPLSESLNHSS	SLC22A14	561	Q9Y267
NSLNVSAISIPEHDE	ALCAM	496	Q13740
SPDVDHIDQVTDDTL	ERCC6L	441	Q2NKX8
TEPSDDDTVSLHSQV	LRCH2	361	Q5VUJ6
SHEPLSVDSVSNNLA	PRDM4	231	Q9UKN5
ADQSTLHAEDPLSIT	PTPRK	806	Q15262
QADFTSLSDQEPLHV	SERPINE1	326	P05121
NLSSNELHVTDPDTD	FREM3	846	P0C091
LDNPELETETSSTHS	FNDC8	156	Q8TC99
DSQGDTEALQEEPSH	FER1L6	26	Q2WGJ9
EPSELQQAGDSDHSE	RTL1	591	A6NKG5
DELSHTSPATNLSDL	RTL3	371	Q8N8U3
SEKEHSLEDNSSPNS	SYTL2	311	Q9HCH5
DPNDNRHSSEILDTL	SPHKAP	691	Q2M3C7
SEGTQHDPLSQESEL	VCX3A	96	Q9NNX9
DTTENLLNTEVHSSP	SIGLEC15	26	Q6ZMC9
SQTSDSEEHPSSENI	RNF157	346	Q96PX1
SEGTQHDPLSQESEL	VCX3B	96	Q9H321
SEGTQHDPLSQESEL	VCY	96	O14598
HPQSSLTLESEAENE	TEX14	956	Q8IWB6
TDLTVLVAHNDDPTD	POLR2E	56	P19388
LTAQSPDIEHLNEVS	SYNE2	5541	Q8WXH0
EDLAPEDNTSSLTHG	LRRC56	311	Q8IYG6
ELSLNTAPHANEDAS	NHS	666	Q6T4R5
ELTAESPQSTDDAHQ	NHS	1551	Q6T4R5
LDDNVSSSSVHDSPL	RGPD2	1251	P0DJD1
PSVLSQVHLSEDEED	TAF1	1841	P21675
EDLPTSESTVHAQEQ	PDPN	81	Q86YL7
LTVAEHDDQEDISPS	GPAM	656	Q9HCL2
HNPQAIDIESEDFSS	ERCC5	181	P28715
EDSSPVVHQSLQEVS	PTPN14	611	Q15678
HSADDILDVSLDPQE	SHROOM2	896	Q13796
EIHSPNIQDSSFDSV	SGO2	1141	Q562F6
TLHELSQSVPQETAE	STARD9	2756	Q9P2P6
QDLEDDLTATPLSHA	SNRK	371	Q9NRH2
LTSQTNLHLEEASED	SNX7	371	Q9UNH6
LDSTDTYPQHAQSLD	SORBS2	31	O94875
HDVSPTSTDTEAQLT	AHNAK2	291	Q8IVF2
DFEEHSTQQLTLSPA	CNNM1	871	Q9NRU3
LTDPSQESHTEAISD	DNTTIP2	171	Q5QJE6
FETQPLDQISEESHN	XIRP2	1216	A4UGR9
HLEQEPTNLRESSLS	TMEM59	191	Q9BXS4
HPTENLIASAALEND	WDR5B	306	Q86VZ2
SDLSQEHLTSNEEIL	TIAM1	186	Q13009
NEVSSSPQHLLATTD	TNN	336	Q9UQP3
SQEDSNLSEELSHSA	TTI2	11	Q6NXR4
TSTLLSALQSHPEEE	STKLD1	416	Q8NE28
EIPTDFNLLQESETH	STAG2	6	Q8N3U4
NPDDSTSEDGIHTLT	PSD2	396	Q9BQI7
HSIIISDQVPSDQDA	TSPYL1	16	Q9H0U9
QLTVTSSDHPEDTAN	SPINT1	221	O43278
REAELSHPSSDSEEN	TRPM3	1611	Q9HCF6
SDVSASESPQHDVVD	TMEM102	211	Q8N9M5
DPDTLENQATVEFHS	PHF3	781	Q92576
DETNLETSTLDENHP	SPATA7	511	Q9P0W8
ETSTLDENHPSISDS	SPATA7	516	Q9P0W8
EAEISHLALQDPASD	TACC2	1481	O95359
VDAVELEPSHSQTLS	SUCO	716	Q9UBS9
TPIQEEQADAHSTLA	TNFRSF4	261	P43489
PDSEHILATSSQDNS	WDR59	201	Q6PJI9
TVNTPHNREADEESL	ZBTB1	166	Q9Y2K1
NLEQTLDDHSSSITA	WDR62	571	O43379
VPDLSDSIHSANASE	TJP1	271	Q07157
SQDLDSRQHPEESSE	TJP1	1111	Q07157
DKNDEHVLPSTSSSD	ZGRF1	721	Q86YA3
SDSELQHISDSPIID	ZBTB2	316	Q8N680
VTESRQHELSPDSNL	TMEM129	191	A0AVI4
SDHESEQLGSISVEP	ZC3H12C	96	Q9C0D7
NDTENHQPVSLSDLE	ZNF75A	76	Q96N20
LTPDSEHALEDVDLN	TRMT10B	211	Q6PF06
TADAPSLLQHDEVET	THOP1	456	P52888
DQALHTQTDADPAEE	THOP1	561	P52888
AAELDSHTPALEQQT	TET2	1071	Q6N021
PSQEEDRHSNASQSL	PPP6R3	201	Q5H9R7
DIANLEASVLENPSH	ZFC3H1	1346	O60293
SPLNSSASQEELHQD	ZNF318	1616	Q5VUA4
PSNEELQSSTSLEHR	WNK4	781	Q96J92
TDPNSESLISAHDIL	ZNF282	351	Q9UDV7
NLNDSLSSTLHDAVE	KIAA0586	1256	Q9BVV6
LDEPLERTTNSSHAN	UBR5	1691	O95071
HSETIDLNLDSIQPA	NAALADL2	76	Q58DX5